Literature DB >> 6538273

Multifocal CT enhancement in MS.

G C Ebers, F V Vinuela, T Feasby, B Bass.   

Abstract

Review of 146 CTs in 125 MS patients showed that 53.4% (39/73) of those done during acute relapse showed enhancing lesions. Of scans done during the "active" stage of disease, 40.8% (20/49) showed enhancement, whereas only 12.5% (3/24) showed enhancement during clinically inactive periods. Autopsy confirmation that enhancing lesions represent demyelinating plaques was obtained in one patient. This study shows that enhancing lesions in MS reflect biologic activity and are most likely to be seen during acute clinically apparent relapses. More than one-half of the patients hospitalized with acute attacks appeared to be having multifocal relapses. These findings show that acute relapses are commonly multifocal and suggest that they are mediated by blood-borne factors.

Entities:  

Mesh:

Year:  1984        PMID: 6538273     DOI: 10.1212/wnl.34.3.341

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  10 in total

1.  The diagnostic challenge of multiple sclerosis.

Authors:  T P Seland
Journal:  Can Fam Physician       Date:  1984-07       Impact factor: 3.275

2.  Acute monophasic focal demyelinating diseases of the central nervous system: longitudinal clinico-neuroradiological study of two patients.

Authors:  P Di Bella; F Logullo; M Danni; F Angeleri; L Chiaramoni; M Maricotti; N Foschi; U Salvolini
Journal:  Ital J Neurol Sci       Date:  1992-12

3.  Short-term neurophysiological monitoring in multiple sclerosis bouts. Evaluation of steroid treatment.

Authors:  V Scaioli; C Milanese; A Salmaggi; L LaMantia; A Campi; M Eoli; F Panzica
Journal:  Ital J Neurol Sci       Date:  1992-03

4.  Computed tomography in cases of multiple sclerosis: problems of differential diagnosis in cases with atypical findings.

Authors:  M Mohadjer; J Kohler; E Milios; F Mundinger
Journal:  Neurosurg Rev       Date:  1988       Impact factor: 3.042

5.  Multiple sclerosis: diagnostic value of computerized tomography with delayed scanning after a double-dose of contrast medium in comparison with other diagnostic tests.

Authors:  C Weitze; G Hertel; W Brittner
Journal:  Neurosurg Rev       Date:  1988       Impact factor: 3.042

6.  Assessing the values of circulating immune complexes in multiple sclerosis patients following immunomodulator or corticosteroid treatment.

Authors:  Any Docu Axelerad; Alina Zorina Stroe; Anca Elena Gogu; Daniel Docu Axelerad
Journal:  Exp Ther Med       Date:  2021-03-23       Impact factor: 2.447

7.  Quantitative assessment of blood-brain barrier permeability in multiple sclerosis using 68-Ga-EDTA and positron emission tomography.

Authors:  C Pozzilli; S Bernardi; L Mansi; P Picozzi; F Iannotti; B Alfano; L Bozzao; G L Lenzi; M Salvatore; P Conforti
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-08       Impact factor: 10.154

8.  Relationship of nuclear magnetic resonance examinations to clinical data, cerebrospinal fluid findings and visual evoked potentials in multiple sclerosis.

Authors:  D Uhlenbrock; E Herbe; M Haupts
Journal:  Neurosurg Rev       Date:  1987       Impact factor: 3.042

9.  Magnetic resonance imaging in multiple sclerosis: diagnostic value and clinical correlations.

Authors:  C Milanese; M Savoiardo; L La Mantia; A Campi; A Visciani; A Salmaggi; L Tajoli Malesani
Journal:  Ital J Neurol Sci       Date:  1988-04

Review 10.  Central nervous system myelin: structure, function, and pathology.

Authors:  C M Deber; S J Reynolds
Journal:  Clin Biochem       Date:  1991-04       Impact factor: 3.281

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.